Literature DB >> 15163901

A novel lymphocyte signaling defect: trk A mutation in the syndrome of congenital insensitivity to pain and anhidrosis (CIPA).

I Melamed1, J Levy, R Parvari, E W Gelfand.   

Abstract

Congenital insensitivity to pain with anhidrosis is a syndrome characterized by loss of pain and sensation. The condition frequently evolves into deep wounds and prolonged healing times. Anhidrosis is another prominent component of the disorder. Often associated with recurrent episodes of unexplained fever, it can result in patient mortality. Recent investigations point to Trk A, the high affinity receptor for nerve growth factor (NGF), as a candidate for the site of the mutation that causes the disorder. Functional NGF receptors, such as Trk A and the Trk family of tyrosine kinases, are essential for NGF signaling of human lymphocytes. In this study, we demonstrated that the presence of a trk A mutation in patient B cells results in a novel lymphocyte signaling defect. In these B cells, NGF failed to induce Trk A phosphorylation, cytoskeleton assembly, or MAP kinase activation. These abnormalities may explain some of the clinical features of the disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15163901     DOI: 10.1023/B:JOCI.0000029106.84310.5e

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  42 in total

Review 1.  Growth cone guidance: first steps towards a deeper understanding.

Authors:  B K Mueller
Journal:  Annu Rev Neurosci       Date:  1999       Impact factor: 12.449

2.  Inhibitors of p38 mitogen-activated protein kinase promote neuronal survival in vitro.

Authors:  S Horstmann; P J Kahle; G D Borasio
Journal:  J Neurosci Res       Date:  1998-05-15       Impact factor: 4.164

Review 3.  Mitogen-activated protein kinase pathways.

Authors:  M J Robinson; M H Cobb
Journal:  Curr Opin Cell Biol       Date:  1997-04       Impact factor: 8.382

Review 4.  Physiology of nerve growth factor.

Authors:  H Thoenen; Y A Barde
Journal:  Physiol Rev       Date:  1980-10       Impact factor: 37.312

5.  SH3 domain-dependent interaction of the proto-oncogene product Vav with the focal contact protein zyxin.

Authors:  O Hobert; J W Schilling; M C Beckerle; A Ullrich; B Jallal
Journal:  Oncogene       Date:  1996-04-04       Impact factor: 9.867

6.  Tyrosine-phosphorylated Vav1 as a point of integration for T-cell receptor- and CD28-mediated activation of JNK, p38, and interleukin-2 transcription.

Authors:  S P Hehner; T G Hofmann; O Dienz; W Droge; M L Schmitz
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

7.  Borna disease virus persistent infection activates mitogen-activated protein kinase and blocks neuronal differentiation of PC12 cells.

Authors:  A Hans; S Syan; C Crosio; P Sassone-Corsi; M Brahic; D Gonzalez-Dunia
Journal:  J Biol Chem       Date:  2000-11-09       Impact factor: 5.157

8.  Nerve growth factor: a chemotactic factor for polymorphonuclear leukocytes in vivo.

Authors:  M D Boyle; M J Lawman; A P Gee; M Young
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

9.  A novel NTRK1 mutation associated with congenital insensitivity to pain with anhidrosis.

Authors:  A Greco; R Villa; B Tubino; L Romano; D Penso; M A Pierotti
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

10.  Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly.

Authors:  K Burridge; C E Turner; L H Romer
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

View more
  9 in total

1.  Humoral immunodeficiency in congenital insensitivity to pain with anhidrosis.

Authors:  Sara Sebnem Kilic; Rifatcan Ozturk; Bartu Sarisozen; Annelies Rotthier; Jonathan Baets; Vincent Timmerman
Journal:  Neurogenetics       Date:  2008-12-17       Impact factor: 2.660

2.  Multidisciplinary assessment of congenital insensitivity to pain syndrome.

Authors:  Vugar Nabiyev; Ateş Kara; M Cemalettin Aksoy
Journal:  Childs Nerv Syst       Date:  2016-03-21       Impact factor: 1.475

3.  Congenital insensitivity to pain and anhydrosis due to a rare mutation and that is complicated by inflammatory bowel disease and amyloidosis: a case report.

Authors:  Faris G Bakri; Ayman Wahbeh; Awni Abu Sneina; Ali Al Khader; Fatima Obeidat; Izzat AlAwwa; Maryam Buni; Chang-Seok Ki; Amira Masri
Journal:  Clin Case Rep       Date:  2016-09-12

Review 4.  NGF and Its Receptors in the Regulation of Inflammatory Response.

Authors:  Gaetana Minnone; Fabrizio De Benedetti; Luisa Bracci-Laudiero
Journal:  Int J Mol Sci       Date:  2017-05-11       Impact factor: 5.923

5.  The Orthopedic Manifestations of Congenital Insensitivity to Pain: A Population-based Study.

Authors:  Maximillian Mifsud; Michelle Spiteri; Karl Camilleri; Matthew Bonello; Thomas Azzopardi; Massimo Abela
Journal:  Indian J Orthop       Date:  2019 Sep-Oct       Impact factor: 1.251

6.  Population Study of Hand and Wrist Manifestations of Congenital Insensitivity to Pain.

Authors:  Michelle Spiteri; Maximillian Mifsud; Thomas Azzopardi; Henk Giele
Journal:  Hand (N Y)       Date:  2020-03-06

7.  Update Review and Clinical Presentation in Congenital Insensitivity to Pain and Anhidrosis.

Authors:  L M Pérez-López; M Cabrera-González; D Gutiérrez-de la Iglesia; S Ricart; G Knörr-Giménez
Journal:  Case Rep Pediatr       Date:  2015-10-22

8.  Novel NTRK1 mutations in Chinese patients with congenital insensitivity to pain with anhidrosis.

Authors:  Xingzhu Geng; Yanshan Liu; XiuZhi Ren; Yun Guan; Yanzhou Wang; Bin Mao; Xiuli Zhao; Xue Zhang
Journal:  Mol Pain       Date:  2018-05-17       Impact factor: 3.395

9.  Clinical, genomics and networking analyses of a high-altitude native American Ecuadorian patient with congenital insensitivity to pain with anhidrosis: a case report.

Authors:  Andrés López-Cortés; Ana Karina Zambrano; Patricia Guevara-Ramírez; Byron Albuja Echeverría; Santiago Guerrero; Eliana Cabascango; Andy Pérez-Villa; Isaac Armendáriz-Castillo; Jennyfer M García-Cárdenas; Verónica Yumiceba; Gabriela Pérez-M; Paola E Leone; César Paz-Y-Miño
Journal:  BMC Med Genomics       Date:  2020-08-17       Impact factor: 3.063

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.